Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center,Tehran, Iran (2006-2013)
- PMID: 25549596
Distribution of primary immunodeficiency disorders diagnosed in a tertiary referral center,Tehran, Iran (2006-2013)
Abstract
Background: Primary immunodeficiency disorders (PID) are a group of hereditary disorders characterized by an increased susceptibility to severe and recurrent infections, autoimmunity, lymphoproliferative disorders, and malignancy.
Objective: To evaluate the demographic and clinical data of PID patients diagnosed in a referral pediatric hospital.
Method: All PID cases with a confirmed diagnosis, according to the criteria of International Union of Immunological Societies, who were referred to the Children's Medical Center in Tehran, Iran, between March 2006 and March 2013 were enrolled in this retrospective cohort study.
Results: Three-hundred and seven PID patients were investigated. Predominantly antibody deficiencies were the most common group of PID observed in 118 cases (38.4%), followed by the well-defined syndromes with immunodeficiency in 52 (16.9%), congenital defects of phagocyte in 45 (14.7%), combined immunodeficiencies in 36 (11.7%), autoinflammatory disorders in 34 (11.4%), immune dysregulation in 11 (3.6%), complement deficiencies in 7 (2.3%), and defects in innate immunity in 3 (1%). Selective IgA deficiency was the most prevalent disorder which affected 46 individuals (14.9%). The median diagnostic delay was 15 months.
Conclusion: Increased awareness and availability of diagnostic tests could result in the better recognition of more undiagnosed PID cases and a decrease in diagnostic delay.
Similar articles
-
Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.J Clin Immunol. 2014 May;34(4):478-90. doi: 10.1007/s10875-014-0001-z. J Clin Immunol. 2014. PMID: 24659230
-
Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre.Allergol Immunopathol (Madr). 2016 Jul-Aug;44(4):322-30. doi: 10.1016/j.aller.2015.09.006. Epub 2016 Jan 20. Allergol Immunopathol (Madr). 2016. PMID: 26803694
-
Primary immunodeficiency diseases in Northern Iran.Allergol Immunopathol (Madr). 2017 May-Jun;45(3):244-250. doi: 10.1016/j.aller.2016.11.001. Epub 2017 Feb 22. Allergol Immunopathol (Madr). 2017. PMID: 28237128
-
Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).J Clin Immunol. 2015 Nov;35(8):745-53. doi: 10.1007/s10875-015-0206-9. Epub 2015 Oct 13. J Clin Immunol. 2015. PMID: 26464197 Review.
-
Hematological Malignancies Associated With Primary Immunodeficiency Disorders.Clin Immunol. 2018 Sep;194:46-59. doi: 10.1016/j.clim.2018.06.011. Epub 2018 Jul 4. Clin Immunol. 2018. PMID: 29966714 Review.
Cited by
-
Systematic screening for primary immunodeficiencies in patients hospitalized for severe infection in pediatric intensive care unit.Sci Rep. 2025 Jul 1;15(1):22170. doi: 10.1038/s41598-025-02870-7. Sci Rep. 2025. PMID: 40593888 Free PMC article.
-
The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?J Clin Immunol. 2015 Apr;35(3):273-9. doi: 10.1007/s10875-015-0149-1. Epub 2015 Mar 8. J Clin Immunol. 2015. PMID: 25749910
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous